Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293799748> ?p ?o ?g. }
- W4293799748 endingPage "14" @default.
- W4293799748 startingPage "1" @default.
- W4293799748 abstract "As the number and proportion of lymphocyte subsets are an important indicator of the immune function, an in depth understanding of the immune function of patients with malignant tumor has important clinical values for the treatment, prognosis, and evaluation of the disease. This retrospective study was to evaluate the clinical value of the absolute counts of lymphocyte subsets as potential blood biomarkers for progression and prognosis in breast cancer patients.A total of 237 BC patients and 55 age-matched female normal healthy donors were included in this study. Flow cytometry was used to determine the absolute counts and the percentages of CD3+, CD4+, CD8+, B, and NK cells. The receiver operating characteristic curve (ROC) was used to evaluate the accuracy of absolute count of lymphocyte subsets in the curative efficacy assessment. The clinicopathological parameters influencing the disease progression were determined by Cox proportional hazards regression. Progression-free survival (PFS) was estimated using the Kaplan-Meier method with the log-rank test. Results: Compared with the healthy donors, the absolute counts of lymphocyte subsets in patients decreased significantly. ROC analysis showed that the area under the curve of the CD4+ absolute count was 90% (95% confidence interval 0.859-0.940), and the sensitivity and specificity were 80.9% and 85.3%, respectively. The analysis of Cox regression showed that the cutoff value of the CD4+ absolute count ≥451 cells/μL might be a favorable prognostic factor. Multivariate analysis of prognostic factors of PFS showed that the CD4+ and CD8+ absolute count were independent factors for predicting PFS.The remarkably impaired absolute counts of the CD3+, CD4+, CD8+, B, and NK cells in patients with breast cancer can be used as potential susceptible biomarkers to evaluate the patient's immune status. The higher level of CD4+ and CD8+ absolute counts probably contributed to the longer PFS and favorable outcome of BC patients." @default.
- W4293799748 created "2022-08-31" @default.
- W4293799748 creator A5005985350 @default.
- W4293799748 creator A5009613920 @default.
- W4293799748 creator A5014297063 @default.
- W4293799748 creator A5022304387 @default.
- W4293799748 creator A5025206915 @default.
- W4293799748 creator A5025550016 @default.
- W4293799748 creator A5034524547 @default.
- W4293799748 creator A5042649765 @default.
- W4293799748 creator A5049377516 @default.
- W4293799748 creator A5058590640 @default.
- W4293799748 creator A5062432526 @default.
- W4293799748 creator A5065100460 @default.
- W4293799748 creator A5083617730 @default.
- W4293799748 date "2022-08-18" @default.
- W4293799748 modified "2023-10-14" @default.
- W4293799748 title "The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients" @default.
- W4293799748 cites W2019607817 @default.
- W4293799748 cites W2110718030 @default.
- W4293799748 cites W2264544376 @default.
- W4293799748 cites W2294216513 @default.
- W4293799748 cites W2295156297 @default.
- W4293799748 cites W2412816857 @default.
- W4293799748 cites W2604419819 @default.
- W4293799748 cites W2638401050 @default.
- W4293799748 cites W2762545332 @default.
- W4293799748 cites W2762602728 @default.
- W4293799748 cites W2767254182 @default.
- W4293799748 cites W2778813524 @default.
- W4293799748 cites W2784989383 @default.
- W4293799748 cites W2791153774 @default.
- W4293799748 cites W2794617965 @default.
- W4293799748 cites W2801307887 @default.
- W4293799748 cites W2803081151 @default.
- W4293799748 cites W2884754721 @default.
- W4293799748 cites W2887280975 @default.
- W4293799748 cites W2889669338 @default.
- W4293799748 cites W2909793574 @default.
- W4293799748 cites W2938678047 @default.
- W4293799748 cites W2938872243 @default.
- W4293799748 cites W2943769232 @default.
- W4293799748 cites W2948441881 @default.
- W4293799748 cites W2966854567 @default.
- W4293799748 cites W2969737037 @default.
- W4293799748 cites W2971459028 @default.
- W4293799748 cites W2972520383 @default.
- W4293799748 cites W2980895498 @default.
- W4293799748 cites W2994331021 @default.
- W4293799748 cites W3005326482 @default.
- W4293799748 cites W3005348543 @default.
- W4293799748 cites W3011919016 @default.
- W4293799748 cites W3014346486 @default.
- W4293799748 cites W3017447724 @default.
- W4293799748 cites W3020680705 @default.
- W4293799748 cites W3030888252 @default.
- W4293799748 cites W3047617082 @default.
- W4293799748 cites W3048641542 @default.
- W4293799748 cites W3081864380 @default.
- W4293799748 cites W3091115898 @default.
- W4293799748 cites W3092192838 @default.
- W4293799748 cites W3128291835 @default.
- W4293799748 cites W3128646645 @default.
- W4293799748 cites W4223462256 @default.
- W4293799748 cites W4226019578 @default.
- W4293799748 doi "https://doi.org/10.1155/2022/3444360" @default.
- W4293799748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36051923" @default.
- W4293799748 hasPublicationYear "2022" @default.
- W4293799748 type Work @default.
- W4293799748 citedByCount "4" @default.
- W4293799748 countsByYear W42937997482023 @default.
- W4293799748 crossrefType "journal-article" @default.
- W4293799748 hasAuthorship W4293799748A5005985350 @default.
- W4293799748 hasAuthorship W4293799748A5009613920 @default.
- W4293799748 hasAuthorship W4293799748A5014297063 @default.
- W4293799748 hasAuthorship W4293799748A5022304387 @default.
- W4293799748 hasAuthorship W4293799748A5025206915 @default.
- W4293799748 hasAuthorship W4293799748A5025550016 @default.
- W4293799748 hasAuthorship W4293799748A5034524547 @default.
- W4293799748 hasAuthorship W4293799748A5042649765 @default.
- W4293799748 hasAuthorship W4293799748A5049377516 @default.
- W4293799748 hasAuthorship W4293799748A5058590640 @default.
- W4293799748 hasAuthorship W4293799748A5062432526 @default.
- W4293799748 hasAuthorship W4293799748A5065100460 @default.
- W4293799748 hasAuthorship W4293799748A5083617730 @default.
- W4293799748 hasBestOaLocation W42937997481 @default.
- W4293799748 hasConcept C10515644 @default.
- W4293799748 hasConcept C121608353 @default.
- W4293799748 hasConcept C126322002 @default.
- W4293799748 hasConcept C143998085 @default.
- W4293799748 hasConcept C167672396 @default.
- W4293799748 hasConcept C203014093 @default.
- W4293799748 hasConcept C2777761686 @default.
- W4293799748 hasConcept C44249647 @default.
- W4293799748 hasConcept C50382708 @default.
- W4293799748 hasConcept C530470458 @default.
- W4293799748 hasConcept C58471807 @default.
- W4293799748 hasConcept C71924100 @default.